lobbying_activities: 1727730

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1727730	ecf0cdcb-1c96-478b-90b3-73472dde9488	Q3	MEHLMAN CONSULTING, INC.	284950	VALEANT PHARMACEUTICAL NORTH AMERICA LLC	2015	third_quarter	LBR	Corporate structure.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2015-10-09T11:47:54.737000-04:00